Reports for EMTRICITABINE

Ingredient

EMTRICITABINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-EMTRICITABINE-TENOFOVIR 200MG 300MG TABLET Resolved 2023-04-14 2023-05-19 189650
TEVA-EMTRICITABINE/TENOFOVIR 200MG 300MG TABLET Resolved 2020-11-06 2021-01-07 128004
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 200MG 300MG TABLET Resolved 2022-01-26 2022-02-04 153490
AURO-EMTRICITABINE-TENOFOVIR 200MG 300MG TABLET Actual shortage 2024-03-27 2024-05-24 223603
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2022-06-03 2023-02-11 161940
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-04-14 2023-07-07 189653
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-09-15 2023-11-13 204524
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2017-09-27 2017-10-02 23663
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2018-03-05 2018-03-20 41868
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-04-04 2019-05-21 80530

Showing 1 to 10 of 28

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1